Literature DB >> 26884615

Decade-Long Trends (2001-2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction.

Robert J Goldberg1, Raghavendra Charan P Makam2, Jorge Yarzebski2, David D McManus2, Darleen Lessard2, Joel M Gore2.   

Abstract

BACKGROUND: Limited information is available about relatively contemporary trends in the incidence and hospital case-fatality rates of cardiogenic shock in patients hospitalized with acute myocardial infarction. The purpose of this population-based study was to describe decade long trends (2001-2011) in the incidence and hospital case-fatality rates for patients who developed cardiogenic shock during hospitalization for an acute myocardial infarction. METHODS AND
RESULTS: The study population consisted of 5686 residents of central Massachusetts hospitalized with acute myocardial infarction at all 11 medical centers in the Worcester, MA, metropolitan area during 6 biennial periods between 2001 and 2011, who did not have cardiogenic shock at the time of hospital presentation. On average, 3.7% of these patients developed cardiogenic shock during their acute hospitalization with nonsignificant and inconsistent trends noted over time in both crude (3.7% in 2001/2003; 4.5% in 2005/2007; 2.7% in 2009/2011; P=0.19) and multivariable adjusted analyses. The overall in-hospital case-fatality rate for patients who developed cardiogenic shock was 41.4%. The crude and multivariable adjusted odds of dying after cardiogenic shock declined during the most recent study years (47.1% dying in 2001/2003, 42.0% dying in 2005/2007, and 28.6% dying in 2009/2011). Increases in the use of evidence-based cardiac medications, and interventional procedures paralleled the increasing hospital survival trends.
CONCLUSIONS: We found suggestions of a decline in the death, but not incidence, rates of cardiogenic shock over time. These encouraging trends in hospital survival are likely because of advances in the early recognition and aggressive management of patients who develop cardiogenic shock.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  epidemiology; hospitalization; myocardial infarction; secondary prevention; shock, cardiogenic

Mesh:

Year:  2016        PMID: 26884615      PMCID: PMC4794369          DOI: 10.1161/CIRCOUTCOMES.115.002359

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  32 in total

1.  Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction.

Authors:  R J Goldberg; J M Gore; C A Thompson; J H Gurwitz
Journal:  Am Heart J       Date:  2001-01       Impact factor: 4.749

2.  Temporal trends in cardiogenic shock treatment and outcomes among ontario patients with myocardial infarction between 1992 and 2008.

Authors:  Husam M Abdel-Qadir; Joan Ivanov; Peter C Austin; Jack V Tu; Vladimír Dzavík
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-06-28

3.  Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

Authors:  J G Webb; L A Sleeper; C E Buller; J Boland; A Palazzo; E Buller; H D White; J S Hochman
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

4.  Lack of progress in cardiogenic shock: lessons from the GUSTO trials.

Authors:  V Menon; J S Hochman; A Stebbins; M Pfisterer; J Col; R D Anderson; D Hasdai; D R Holmes; E R Bates; E J Topol; R M Califf; E M Ohman
Journal:  Eur Heart J       Date:  2000-12       Impact factor: 29.983

5.  Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development.

Authors:  M G Lindholm; L Køber; S Boesgaard; C Torp-Pedersen; J Aldershvile
Journal:  Eur Heart J       Date:  2003-02       Impact factor: 29.983

6.  Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

Authors:  D R Holmes; E R Bates; N S Kleiman; Z Sadowski; J H Horgan; D C Morris; R M Califf; P B Berger; E J Topol
Journal:  J Am Coll Cardiol       Date:  1995-09       Impact factor: 24.094

Review 7.  Cardiogenic shock: a summary of the randomized SHOCK trial.

Authors:  Venu Menon; Rupert Fincke
Journal:  Congest Heart Fail       Date:  2003 Jan-Feb

8.  Effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction. A single center experience.

Authors:  M G Lindholm; J Aldershvile; C Sundgreen; Erik Jørgensen; Kari Saunamäki; S Boesgaard
Journal:  Eur J Heart Fail       Date:  2003-01       Impact factor: 15.534

9.  Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study.

Authors:  R J Goldberg; J M Gore; J S Alpert; J E Dalen
Journal:  JAMA       Date:  1986 May 23-30       Impact factor: 56.272

10.  A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study.

Authors:  Kevin C Floyd; Jorge Yarzebski; Frederick A Spencer; Darleen Lessard; James E Dalen; Joseph S Alpert; Joel M Gore; Robert J Goldberg
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-03-05
View more
  31 in total

Review 1.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

2.  Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry.

Authors:  David D Berg; Christopher F Barnett; Benjamin B Kenigsberg; Alexander Papolos; Carlos L Alviar; Vivian M Baird-Zars; Gregory W Barsness; Erin A Bohula; Joseph Brennan; James A Burke; Anthony P Carnicelli; Sunit-Preet Chaudhry; Paul C Cremer; Lori B Daniels; Andrew P DeFilippis; Daniel A Gerber; Christopher B Granger; Steven Hollenberg; James M Horowitz; James D Gladden; Jason N Katz; Ellen C Keeley; Norma Keller; Michael C Kontos; Patrick R Lawler; Venu Menon; Thomas S Metkus; P Elliott Miller; Jose Nativi-Nicolau; L Kristin Newby; Jeong-Gun Park; Nicholas Phreaner; Robert O Roswell; Steven P Schulman; Shashank S Sinha; R Jeffrey Snell; Michael A Solomon; Jeffrey J Teuteberg; Wayne Tymchak; Sean van Diepen; David A Morrow
Journal:  Circ Heart Fail       Date:  2019-11-11       Impact factor: 8.790

3.  Comparison of the Hemodynamic Response to Intra-Aortic Balloon Counterpulsation in Patients With Cardiogenic Shock Resulting from Acute Myocardial Infarction Versus Acute Decompensated Heart Failure.

Authors:  Waqas Malick; Justin Allan Fried; Amirali Masoumi; Abhinav Nair; Amelia Zuver; Athena Huang; Jennifer Haythe; Maryjane Farr; LeRoy Rabbani; Dimitri Karmpaliotis; Ajay Jayant Kirtane; Veli Kemal Topkara; Koji Takeda; Arthur Reshad Garan
Journal:  Am J Cardiol       Date:  2019-09-26       Impact factor: 2.778

4.  Predictors of Survival for Patients with Acute Decompensated Heart Failure Requiring Extra-Corporeal Membrane Oxygenation Therapy.

Authors:  A Reshad Garan; Waqas A Malick; Marlena Habal; Veli K Topkara; Justin Fried; Amirali Masoumi; Aws K Hasan; Dimitri Karmpaliotis; Ajay Kirtane; Melana Yuzefpolskaya; Maryjane Farr; Yoshifumi Naka; Dan Burkhoff; Paolo C Colombo; Paul Kurlansky; Hiroo Takayama; Koji Takeda
Journal:  ASAIO J       Date:  2019 Nov/Dec       Impact factor: 2.872

5.  Non-STEMI vs. STEMI Cardiogenic Shock: Clinical Profile and Long-Term Outcomes.

Authors:  María José Martínez; Ferran Rueda; Carlos Labata; Teresa Oliveras; Santiago Montero; Marc Ferrer; Nabil El Ouaddi; Jordi Serra; Josep Lupón; Antoni Bayés-Genís; Cosme García-García
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

6.  Single center first year experience and outcomes with Impella 5.5 left ventricular assist device.

Authors:  Joanna R Rock; Cynthia A Kos; Anthony Lemaire; Hirohisa Ikegami; Mark J Russo; Danyaal Moin; Kenneth Dulnuan; Deepa Iyer
Journal:  J Cardiothorac Surg       Date:  2022-05-23       Impact factor: 1.522

Review 7.  Advancements in mechanical circulatory support for patients in acute and chronic heart failure.

Authors:  Thomas A Csepe; Ahmet Kilic
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

8.  Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction?

Authors:  Essa Hariri; Darleen Lessard; Joel Gore; Jeffrey Rade; Robert Goldberg
Journal:  Cardiovasc Revasc Med       Date:  2019-05-02

9.  Decade Long Trends (2001-2011) in the Incidence Rates of Initial Acute Myocardial Infarction.

Authors:  Robert J Goldberg; Mayra Tisminetzky; Hoang V Tran; Jorge Yarzebski; Darleen Lessard; Joel M Gore
Journal:  Am J Cardiol       Date:  2018-10-19       Impact factor: 2.778

10.  SAcubitril/valsartan versus ramipril in patients with ST-segment Elevation Myocardial Infarction and cardiogenic SHOCK (SAVE-SHOCK): a pilot randomized controlled trial.

Authors:  Ahmed Rezq; Marwan Saad; Mostafa El Nozahi
Journal:  Am J Cardiovasc Dis       Date:  2021-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.